Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker GNPX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 28, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 21, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 18, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 5, 2026 | GNPX Genprex, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Aug 3, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 30, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 30, 2026 | GNPX Genprex, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jul 14, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 14, 2026 | GNPX Genprex, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 14, 2026 | GNPX Genprex, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jul 14, 2026 | GNPX Genprex, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Jun 22, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 18, 2026 | GNPX Genprex, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 18, 2026 | GNPX Genprex, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 12, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 12, 2026 | GNPX Genprex, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| May 26, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 14, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 30, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 28, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 21, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 21, 2026 | GNPX Genprex, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 18, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 23, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 10, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 9, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 7, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 7, 2026 | GNPX Genprex, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 6, 2026 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 23, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 26, 2025 | GNPX Genprex, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Nov 21, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 19, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 18, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 29, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 29, 2025 | GNPX Genprex, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 29, 2025 | GNPX Genprex, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 28, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 24, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 24, 2025 | GNPX Genprex, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 24, 2025 | GNPX Genprex, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 23, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 21, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 17, 2025 | GNPX Genprex, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 17, 2025 | GNPX Genprex, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 17, 2025 | GNPX Genprex, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 17, 2025 | GNPX Genprex, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:10 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances